RSS Feeds | Five Myths About Foot Care August 30, 2007 07:00:00"Dont cross your eyes, theyll stay that way!" Old wives tales and myths like that example are fun to laugh at. We believed them growing up. "Step on a crack and youll break your mothers back." But there are other myths that are no laughing matter, especially when they involve your health. From bunions to broken toes, doctors with the 6,000-member American College of Foot and Ankle Surgeons (ACFAS) have heard it all. [click link for full article] - [Read more] |
| Mysteries Of Bones Strength Probed By MIT August 29, 2007 21:00:00Scientists and engineers are eager to understand the secret behind bones lightweight toughness so they can mimic it in the design of new materials, but previous studies have revealed a number of different strength mechanisms at different scales of focus, rather than a single theory. [click link for full article] - [Read more] |
| IDM Pharma Receives Not Approvable Letter For Mifamurtide (L-MTP-PE) For The Treatment Of Osteosarco August 28, 2007 07:00:00IDM Pharma, Inc. (Nasdaq: IDMI) announced that it received a not approvable letter from the U.S. Food and Drug Administration (FDA) after completing the review of the new drug application (NDA) for the investigational drug mifamurtide (L-MTP-PE), formerly known as Junovan, for the treatment of non-metastatic osteosarcoma, a rare and often fatal bone tumor that typically affects children and young adults. [click link for full article] - [Read more] |
| Depuy Orthopaedics Launches New Hip Bearing System August 26, 2007 07:00:00DePuy Orthopaedics, Inc., has announced a new option for restoring hip mobility in patients who require total hip replacement: the Pinnacle® Acetabular Cup System AltrX™ hip bearing. This system provides advanced technology for recreating the natural ball and socket joint of the hip to help increase joint stability, range of motion and longevity. [click link for full article] - [Read more] |
| Live Webcast Of Reverse Shoulder Replacement August 24, 2007 21:00:00The Reverse Shoulder Replacement is an FDA approved implant that has been performed successfully for over 10 years in Europe but wasnt regularly performed in the United States until 2004. Dr. Reuben Gobezie, Orthopaedic Surgeon at University Hospitals Case Medical Center (UHCMC), has been at the forefront of surgical advancements with the reverse shoulder replacement since joining the orthopaedic team at UHCMC from Massachusetts General. Dr. [click link for full article] - [Read more] |
| Fracture And Bone Loss Risk Reduced If Older People Take Calcium Supplementation August 24, 2007 11:00:00People over the age of 50 who either take calcium supplementation alone, or along with vitamin D supplementation have a 12% lower risk of fracture or bone loss, compared to people who dont take them, says an article in The Lancet, this weeks issue. Dr. Benjamin Tang, University of Western Sydney, Australia, and team carried out an analysis of 17 previous studies involving 52,625 people over the age of 50. They each received treatment for an average of 3.5 years. [click link for full article] - [Read more] |
| Postmenopausal Osteoporosis Treatment Reclast Approved By FDA August 22, 2007 19:00:00The U.S. Food and Drug Administration (FDA) has approved Reclast® (zoledronic acid) Injection, the first and only once-yearly treatment for postmenopausal osteoporosis. Approximately 8 million women in the United States suffer from osteoporosis, a disease characterized by low bone mass and reduced bone strength that causes bones to break easily. Osteoporotic fractures are associated with increased morbidity, mortality and healthcare costs. [click link for full article] - [Read more] |
| Aclasta Receives US FDA Approval As First And Only Once-Yearly Treatment For Women With Postmenopaus August 22, 2007 08:00:00Aclasta (zoledronic acid 5mg) has been approved by the US Food and Drug Administration (FDA) under the brand name Aclasta® Injection as the first and only once-yearly medicine for postmenopausal osteoporosis, offering an important new approach to the treatment of a bone disease affecting eight million women in the US1. Unlike oral bisphosphonate therapies that have to be taken daily, weekly or monthly, Aclasta is given as a once-yearly 15-minute intravenous (IV) infusion. [click link for full article] - [Read more] |
| In Light Of Surging Sales Of Painkillers, Physical Therapists Urge Consumers To Seek Physical Therap August 22, 2007 07:00:00According to a new Associated Press analysis of federal drug prescription data, retail sales of five leading painkillers nearly doubled from 1997 to 2005, reflecting a surge in use by patients nationwide who are living in pain. In light of this provocative information, patients may wish to consider the benefits of a physical therapists intervention for pain relief from certain chronic conditions, says the American Physical Therapy Association (APTA). [click link for full article] - [Read more] |
| School Is Around The Corner - Make Sure The Shoe Fits Before Wearing IT August 21, 2007 09:00:00As saddle shoes and penny loafers have come and gone, healthy feet are meant to last a lifetime. Parents may have already begun the annual back-to-school shopping expedition with their children, where school shoes are likely be purchased. According to the American Academy of Orthopaedic Surgeons (AAOS), parents buying back-to-school gear should make sure their children have properly fitting shoes that offer both protection and comfort. [click link for full article] - [Read more] |
| IOF To Launch Risk Factor Campaign As Part Of World Osteoporosis Day 2007 August 21, 2007 08:00:00The International Osteoporosis Foundation (IOF) is preparing one of its most far-reaching campaigns ever, for launch on World Osteoporosis Day 2007, celebrated worldwide on October 20. Entitled, Beat the Break: Know and reduce your osteoporosis risk, the year-long campaign calls on people to discover if they are at risk of osteoporosis by completing a simple questionnaire, the IOF One-Minute Osteoporosis Risk Test. [click link for full article] - [Read more] |
| Once A Year Osteoporosis Drug Reclast Gets FDA Approval August 21, 2007 07:00:00Swiss drug maker Novartis announced that Reclast (zoledronic acid) has received approval from the US Food and Drug Administration (FDA) as a once a year treatment for women with osteoporosis.Osteoporosis (literally means "porous bones") occurs when bone mineral density (BMD) falls and the physical and chemical structure inside bones is disrupted leading to skeletal fragility and bones that fracture easily (it is sometimes called brittle bone disease). [click link for full article] - [Read more] |
| Reclast Receives US Regulatory Approval As First And Only Once-yearly Treatment For Women With Postm August 20, 2007 07:00:00Reclast (zoledronic acid) Injection has been approved by the US Food and Drug Administration as the first and only once-yearly medicine for postmenopausal osteoporosis, offering an important new approach to the treatment of a bone disease affecting eight million women in the US[1]. Unlike oral bisphosphonate therapies that have to be taken daily, weekly or monthly, Reclast is given as a once-yearly 15-minute intravenous (IV) infusion. [click link for full article] - [Read more] |
| New Online Resource For Patients With Severe Hip Osteoarthritis August 20, 2007 07:00:00DePuy Orthopaedics, Inc., announced an advancement in online education for the more than 200,000 Americans who undergo hip replacement each year.1 This extensive patient Web site, http://www.hipreplacement.com, provides hip pain patients with a broad range of resources from mobility assessment tools to surgical options and recovery information, as well as linking to an online discussion group for peer-to-peer support. [click link for full article] - [Read more] |
| Interleukin Genetics Initiates Study Of Genetics Of Osteoarthritis With New York University Medical August 17, 2007 07:00:00Interleukin Genetics, Inc. (Amex: ILI) announced today that it has initiated a study on the genetics of osteoarthritis in collaboration with Dr. Steven Abramson, Director of the Division of Rheumatology at the Hospital for Joint Diseases of New York University Medical Center. Osteoarthritis (OA) is the breakdown of the cartilage cushion in one or more joints of the body leading to pain, to limitation in movement, and in many cases to joint replacement. [click link for full article] - [Read more] |
| Auxilium Pharmaceuticals, Inc. Receives Clearance To Resume Clinical Trials For XIAFLEX(TM) August 17, 2007 07:00:00Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) today announced that the Company has received clearance from the U.S. Food and Drug Administration ("FDA") to resume its phase III clinical trials for XIAFLEX (clostridial collagenase for injection), formerly referred to as AA4500, in the treatment of Dupuytrens contracture. The Company will hold a conference call today, August 16, at 10:00 a.m. Eastern Time to discuss this news. [click link for full article] - [Read more] |
| Stress Fracture Risk In Active Adolescent Girls May Be Hereditary August 15, 2007 10:00:00For active teen girls and young women, heredity may be more important than the type of sports or exercise they engage in as a risk factor for stress fractures, according to the study, "Family History Predicts Stress Fracture in Active Female Adolescents." Stress fractures are bone defects resulting from repeated application of normal forces. They are especially of concern in active teen girls and young women, as they can indicate bone insufficiency. [click link for full article] - [Read more] |
|
|